Analysis of chemoimmunotherapy and inflammatory indices in stage III unresectable lung squamous cell carcinoma.

BMC Cancer · 2026 · PMC13326493 · PMID 42106655

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Notably, patients who started treatment at 6–8 weeks showed a trend toward improved PFS and OS compared with those who began at 4–6 weeks [ 9 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.